feed,title,long_url,short_url
Benzinga,Why AbCellera Biologics Is Still A Buy Despite Dropping Royalties: Analyst On Long-Term Prospects,https://benzinga.com/analyst-ratings/analyst-color/23/08/34153752/why-abcellera-biologics-is-still-a-buy-despite-dropping-royalties-analyst-on-long-t,https://da.gd/27B8VW
